Cargando…

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial

BACKGROUND: The risk of stroke according to clinical classification of atrial fibrillation (AF) remains poorly defined. Here, we assessed the impact of AF type on stroke risk in vitamin K antagonist-treated patients with AF in ‘real-world’ and ‘clinical trial’ cohorts. METHODS: Post-hoc analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Wern Yew, Rivera-Caravaca, José Miguel, Marin, Francisco, Roldán, Vanessa, Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259516/ https://www.ncbi.nlm.nih.gov/pubmed/35426602 http://dx.doi.org/10.1007/s11239-022-02638-0

Ejemplares similares

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS
por: Ding, Wern Yew, et al.
Publicado: (2021)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
por: Roldán, Vanessa, et al.
Publicado: (2022)

Residual Stroke Risk in Atrial Fibrillation
por: Ding, Wern Yew
Publicado: (2021)

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA (2) DS (2)‐VASc Scores
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2017)

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation
por: Duncker, David, et al.
Publicado: (2021)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2017)

Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Relationship between lipoproteins, thrombosis, and atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2021)

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
por: García-Fernández, Amaya, et al.
Publicado: (2017)

Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
por: Ding, Wern Yew, et al.
Publicado: (2019)

Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
por: Ding, Wern Yew, et al.
Publicado: (2020)

Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
por: Lim, Hoong Sern, et al.
Publicado: (2004)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
por: Bowrin, Kevin, et al.
Publicado: (2020)

Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes
por: Yew Ding, Wern, et al.
Publicado: (2020)

Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey
por: Potpara, Tatjana S., et al.
Publicado: (2016)

More or Less Irregularity in Understanding an Irregular Rhythm: Atrial Fibrillation Classification and Racial Differences
por: Soliman, Elsayed Z.
Publicado: (2013)

Ablation index-guided 50W radiofrequency ablation for left atrial posterior wall isolation in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Recent advances in rhythm control for atrial fibrillation
por: Bond, Richard, et al.
Publicado: (2017)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
por: Kim, Woojin, et al.
Publicado: (2023)

Early rhythm control vs. rate control in atrial fibrillation: A systematic review and meta-analysis
por: Han, Shaojie, et al.
Publicado: (2023)

Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease
por: Kim, D, et al.
Publicado: (2023)

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review
por: Deng, Hai, et al.
Publicado: (2017)

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_he4bvcmv5dru1thll6nljnbsee